Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
BIOVITE AUSTRALIA PTY LTD currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This 1 pending office action represents the entirety of the company's active prosecution for its biological innovations. In the Biotechnology & Pharmaceuticals sector, maintaining 1 pending office action requires careful management of USPTO deadlines to ensure that the intellectual property protection remains on track with development cycles.
The prosecution is concentrated under 1 distinct examiner and 1 distinct art unit. This focus within 1 distinct art unit suggests that the technical scope of the application is highly specialized and does not cross into other technical disciplines. Because there is only 1 distinct examiner involved, the company's strategy is entirely dependent on the interpretation of a single individual at the patent office.
JUSTICE, GINA CHIEUN YU is the busiest examiner for the portfolio, currently managing 1 pending office action. Since this 1 pending office action is the only one currently active, the interactions with JUSTICE, GINA CHIEUN YU will determine the immediate success of the company's patent efforts. Practitioners should review the specific tendencies of JUSTICE, GINA CHIEUN YU to navigate the 1 pending office action effectively.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JUSTICE, GINA CHIEUN YU | 1 | 55.6% | +8.5% |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18008167 | ANTI-MICROBIAL AND ANTI-INFLAMMATORY COMPOSITION COMPRISING ARTHROSPIRA EXTRACTS AND AN ORGANIC ACID | JUSTICE, GINA CHIEUN YU | 1617 | §103 | Final Rejection | 51d overdue | Pending | Dec 03, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBIOVITE AUSTRALIA PTY LTD has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Gina Chieun Yu Justice has the most, with 1 of BIOVITE AUSTRALIA PTY LTD's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
